Clonidine extended-release was FDA approved in 2009 and guanfacine in 2010, both only for children and adolescents with ADHD, where they are typically considered second-line choices for patients who cannot tolerate stimulants or as adjunctive therapy to enhance stimulant effects.

factualpending

Speaker

Dr. Tracey Marks

Evidence Quote

“Clonidine extended release was FDA approved in 2009, and guanfacine in 2010. They were only approved though for children and adolescents with ADHD”

Source

Rethinking ADHD Treatment: The Power of Non-Stimulant Medication— Dr. Tracey Marks
Created: 8/11/2026, 5:26:50 AM

Your notes

Loading notes...